The Pennsylvania State University

The Pennsylvania State University Penn State Health Division is a tax-exempt, non-profit healthcare provider that serves as the clinical and healthcare delivery arm of The Pennsylvania State University. Operating from its primary facility in Hershey, Pennsylvania, Penn State Health has been registered as a federal contractor and grant recipient since 2004 and maintains active engagement with multiple federal agencies through both direct contract awards and grant sub-award participation. The organization combines clinical service delivery capabilities with research infrastructure, positioning itself as a significant healthcare provider to federal beneficiaries across central and northeastern Pennsylvania, as well as portions of New York and New Jersey.

Penn State Health has established a consistent track record of delivering specialized healthcare services to the Department of Veterans Affairs through a series of delivery order contracts with Veterans Integrated Service Network 4 (VISN 4). Beginning in 2022 and continuing through the current period, the entity has held annual ophthalmology services delivery orders, with contract values ranging from $438,430 to $798,910.56. These contracts are structured as fixed-price agreements with economic price adjustment provisions and are executed without small business set-aside designations, indicating that Penn State Health competes successfully in the open market based on its demonstrated capabilities and qualifications. All five documented federal contract awards focus exclusively on ophthalmology services delivered from the Lebanon, Pennsylvania location, with services provided directly to veterans as part of the VA's healthcare mission. The steady renewal of these annual contracts demonstrates the sustained demand for Penn State Health's specialized medical expertise and institutional capacity to serve veteran populations.

Beyond its contract work, Penn State Health participates in federally funded research initiatives as a sub-award recipient under grants administered through leading research institutions. Recent grant sub-awards include participation in an Appalachian Node research initiative under a University of Pittsburgh prime grant (awarded November 2024), a clinical research project focused on optimal patient positioning during acute ischemic stroke treatment under a University of Tennessee prime grant (awarded December 2023), and photosynthesis and solar energy research under a Rensselaer Polytechnic Institute prime grant (awarded February 2023). These grant engagements reflect Penn State Health's role as a research-capable institution capable of supporting complex scientific and clinical investigations alongside its primary mission of healthcare service delivery. The diversity of grant topics spanning medical treatment protocols, renewable energy research, and biomedical applications demonstrates the breadth of the organization's research infrastructure and its integration within the broader academic research ecosystem.